These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 1409382)

  • 1. Formation of the racemic compound of ephedrine base from a physical mixture of its enantiomers in the solid, liquid, solution, or vapor state.
    Duddu SP; Grant DJ
    Pharm Res; 1992 Aug; 9(8):1083-91. PubMed ID: 1409382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of configuration around the chiral carbon atoms on the crystal properties of ephedrinium and pseudoephedrinium salicylates.
    Duddu SP; Grant DJ
    Pharm Res; 1994 Nov; 11(11):1549-56. PubMed ID: 7870670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel X-ray powder diffractometric method for studying the reaction between pseudoephedrine enantiomers.
    Duddu SP; Khin-Khin A; Grant DJ; Suryanarayanan R
    J Pharm Sci; 1997 Mar; 86(3):340-5. PubMed ID: 9050803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of a solid solution of enantiomers in a racemate-forming system by seeding.
    Huang J; Chen S; Guzei IA; Yu L
    J Am Chem Soc; 2006 Sep; 128(36):11985-92. PubMed ID: 16953640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calorimetric determination of the heat of precipitation of pseudoephedrine racemic compound--its agreement with the heat of solution.
    Pudipeddi M; Sokoloski TD; Duddu SP; Carstensen JT
    J Pharm Sci; 1995 Oct; 84(10):1236-9. PubMed ID: 8801340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solubility, metastable zone width, and racemic characterization of propranolol hydrochloride.
    Wang X; Wang XJ; Ching CB
    Chirality; 2002 May; 14(4):318-24. PubMed ID: 11968072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of racemic species of chiral drugs using thermal analysis, thermodynamic calculation, and structural studies.
    Li ZJ; Zell MT; Munson EJ; Grant DJ
    J Pharm Sci; 1999 Mar; 88(3):337-46. PubMed ID: 10052993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Physicochemical properties of suplatast tosilate racemate and enantiomers].
    Ushio T; Endo K; Yamamoto K
    Yakugaku Zasshi; 1996 Nov; 116(11):866-75. PubMed ID: 8981830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solubility properties of racemic praziquantel and its enantiomers.
    el-Arini SK; Giron D; Leuenberger H
    Pharm Dev Technol; 1998 Nov; 3(4):557-64. PubMed ID: 9834959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of molecular flexibility on double polymorphism, solid solutions and chiral discrimination during crystallization of diprophylline enantiomers.
    Brandel C; Amharar Y; Rollinger JM; Griesser UJ; Cartigny Y; Petit S; Coquerel G
    Mol Pharm; 2013 Oct; 10(10):3850-61. PubMed ID: 23984951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formation of solid solutions between racemic and enantiomeric citalopram oxalate.
    de Diego HL; Bond AD; Dancer RJ
    Chirality; 2011 May; 23(5):408-16. PubMed ID: 21472783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enantiomeric 3-chloromandelic acid system: binary melting point phase diagram, ternary solubility phase diagrams and polymorphism.
    Le Minh T; von Langermann J; Lorenz H; Seidel-Morgenstern A
    J Pharm Sci; 2010 Sep; 99(9):4084-95. PubMed ID: 20575001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of crystallization in the presence of the diastereomer on the crystal properties of (SS)-(+)-pseudoephedrine hydrochloride.
    Gu CH; Grant DJ
    Enantiomer; 2000; 5(3-4):271-80. PubMed ID: 11126867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular modeling study of chiral drug crystals: lattice energy calculations.
    Li ZJ; Ojala WH; Grant DJ
    J Pharm Sci; 2001 Oct; 90(10):1523-39. PubMed ID: 11745711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Permeability of pure enantiomers of ketorolac through human cadaver skin.
    Roy SD; Chatterjee DJ; Manoukian E; Divor A
    J Pharm Sci; 1995 Aug; 84(8):987-90. PubMed ID: 7500285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of the Binary System of Proxyphylline Enantiomers: Structural Resolution and Phase Diagram Determination.
    Pinetre C; Harfouche L; Brandel C; Bendeif EE; Sanselme M; Cartigny Y; Couvrat N; Dupray V
    Mol Pharm; 2024 Feb; 21(2):845-853. PubMed ID: 38134443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of grinding and humidification on the transformation of conglomerate to racemic compound in optically active drugs.
    Piyarom S; Yonemochi E; Oguchi T; Yamamoto K
    J Pharm Pharmacol; 1997 Apr; 49(4):384-9. PubMed ID: 9232535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereospecific formulation and characterization of sustained release ibuprofen microspheres.
    Janjikhel RK; Adeyeye CM
    J Microencapsul; 1997; 14(4):409-26. PubMed ID: 9229341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and proportion of the enantiomers of the antihypertensive drug chlortalidone in its Form II by high quality single-crystal X-ray diffraction data.
    Santos LM; Santos OMM; Mendes PF; Rosa IML; Silva CCD; Bonfilio R; de Araujo MB; Boralli VB; Doriguetto AC; Martins FT
    J Pharm Biomed Anal; 2016 Jan; 118():101-104. PubMed ID: 26528899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solid-Phase and Oscillating Solution Crystallization Behavior of (+)- and (-)-N-Methylephedrine.
    Tulashie SK; Polenske D; Seidel-Morgenstern A; Lorenz H
    J Pharm Sci; 2016 Nov; 105(11):3359-3365. PubMed ID: 27659160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.